FindTrial
Sign In

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Gradual Vs. Rapid Buprenorphine Detoxification

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00000220
Enrollment
0
Registered
1999-09-21
Start date
1991-06-30
Completion date
2001-07-31
Last updated
2005-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders

Brief summary

The purpose of this study is to determine an optimal detoxification dose reduction schedule with buprenorphine.

Interventions

DRUGBuprenorphine

Sponsors

University of Vermont
CollaboratorOTHER
National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
33 Years to 43 Years
Healthy volunteers
No

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

MeasureTime frame
Drug use—
Retention—
Observed withdrawal rating—
Opioid agonist rating—
Opioid antagonist rating—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026